FI882808A - Vid metylaminokvaeve substituerade derivat. - Google Patents

Vid metylaminokvaeve substituerade derivat. Download PDF

Info

Publication number
FI882808A
FI882808A FI882808A FI882808A FI882808A FI 882808 A FI882808 A FI 882808A FI 882808 A FI882808 A FI 882808A FI 882808 A FI882808 A FI 882808A FI 882808 A FI882808 A FI 882808A
Authority
FI
Finland
Prior art keywords
metlaminokvaeve
substituerade
derivat
vid
formula
Prior art date
Application number
FI882808A
Other languages
English (en)
Other versions
FI882808A0 (fi
FI89362B (fi
FI89362C (fi
Inventor
Giorgio Caravatti
Andreas Fredenhagen
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI882808A0 publication Critical patent/FI882808A0/fi
Publication of FI882808A publication Critical patent/FI882808A/fi
Publication of FI89362B publication Critical patent/FI89362B/fi
Application granted granted Critical
Publication of FI89362C publication Critical patent/FI89362C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
FI882808A 1987-06-15 1988-06-13 Foerfarande foer framstaellning av nya terapeutiskt verkande i metylaminkvaeve acylerade staurosporinderivat FI89362C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH224487 1987-06-15
CH224487 1987-06-15
CH144088 1988-04-19
CH144088 1988-04-19

Publications (4)

Publication Number Publication Date
FI882808A0 FI882808A0 (fi) 1988-06-13
FI882808A true FI882808A (fi) 1988-12-16
FI89362B FI89362B (fi) 1993-06-15
FI89362C FI89362C (fi) 1993-09-27

Family

ID=25687663

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882808A FI89362C (fi) 1987-06-15 1988-06-13 Foerfarande foer framstaellning av nya terapeutiskt verkande i metylaminkvaeve acylerade staurosporinderivat

Country Status (20)

Country Link
EP (1) EP0296110B1 (fi)
JP (1) JP2708047B2 (fi)
KR (1) KR970001529B1 (fi)
AT (1) ATE134375T1 (fi)
AU (1) AU617324B2 (fi)
CA (1) CA1337763C (fi)
DE (1) DE3855015D1 (fi)
DK (1) DK175507B1 (fi)
ES (1) ES2083956T3 (fi)
FI (1) FI89362C (fi)
GR (1) GR3019064T3 (fi)
HK (1) HK1003788A1 (fi)
HU (1) HU201329B (fi)
IE (1) IE70523B1 (fi)
IL (1) IL86632A0 (fi)
MY (1) MY104316A (fi)
NO (1) NO170634C (fi)
NZ (1) NZ225018A (fi)
PT (1) PT87719B (fi)
YU (1) YU115488A (fi)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62220196A (ja) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ｕｃｎ―０１
JP2766360B2 (ja) * 1988-02-04 1998-06-18 協和醗酵工業株式会社 スタウロスポリン誘導体
SK278989B6 (sk) * 1988-02-10 1998-05-06 F. Hoffmann-La Roche Ag Substituované pyroly, ich použitie na výrobu lieči
USRE36736E (en) * 1989-02-06 2000-06-13 Hoffman-La Roche Inc. Substituted pyrroles
DE3924538A1 (de) * 1989-07-25 1991-01-31 Goedecke Ag Indolocarbazol und dessen verwendung
US5618809A (en) * 1989-12-14 1997-04-08 Schering Corporation Indolocarbazoles from saccharothrix aerocolonigenes copiosa subsp. nov SCC 1951 ATCC 53856
US5292747A (en) * 1990-08-07 1994-03-08 Hoffman-La Roche Inc. Substituted pyrroles
WO1993007153A1 (en) * 1991-10-10 1993-04-15 Schering Corporation 4'-(n-substituted-n-oxide)staurosporine derivatives
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
WO1993018771A1 (fr) * 1992-03-24 1993-09-30 Asahi Kasei Kogyo Kabushiki Kaisha INHIBITEUR DE L'AGGLUTINATION PLAQUETTAIRE CONTENANT UN DERIVE DE STAUROSPORINE η-LACTAME
US5621101A (en) * 1992-07-24 1997-04-15 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
US5461146A (en) * 1992-07-24 1995-10-24 Cephalon, Inc. Selected protein kinase inhibitors for the treatment of neurological disorders
US5621100A (en) * 1992-07-24 1997-04-15 Cephalon, Inc. K-252a derivatives for treatment of neurological disorders
US5756494A (en) * 1992-07-24 1998-05-26 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
WO1994006799A1 (fr) * 1992-09-21 1994-03-31 Kyowa Hakko Kogyo Co., Ltd. Remede contre la thrombopenie
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
EP1447098A3 (en) 1993-01-28 2005-06-29 Boston Scientific Limited Therapeutic inhibitor of vascular smooth muscle cells
PH30300A (en) * 1993-05-07 1997-01-20 Ciba Geigy Ag Polycyclic compounds and processes for the preparation thereof
US6051221A (en) * 1993-07-09 2000-04-18 Glaxo Wellcome Inc. BRK protein tyrosine kinase and encoding nucleic acid
GB9325395D0 (en) * 1993-12-11 1994-02-16 Ciba Geigy Ag Compositions
EP0711556A1 (de) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Intravenöse Lösungen für ein Staurosporinderivat
UA67725C2 (en) 1996-06-03 2004-07-15 Cephalon Inc K-252a derivatives and a method for improvement of functioning and cell survival enhancement
US6875865B1 (en) 1996-06-03 2005-04-05 Cephalon, Inc. Selected derivatives of K-252a
PT912184E (pt) 1996-06-25 2002-12-31 Cephalon Inc Utilizacao de um derivado de k-252a para o tratamento de doencas do sietma nervoso central ou periferico e sobre-producao de citoquina
EP0975340B2 (en) 1997-03-31 2009-10-28 Boston Scientific Limited Therapeutic inhibitor of vascular smooth muscle cells
AU761092B2 (en) * 1998-11-23 2003-05-29 Novartis Ag Use of staurosporine derivatives for treating ocular neovascular diseases
DK3143995T3 (en) 2001-02-19 2019-01-28 Novartis Pharma Ag Rapamycin derivative for the treatment of lung cancer
EP2253319A1 (en) 2001-05-16 2010-11-24 Novartis AG Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent.
NZ532136A (en) 2001-10-30 2006-08-31 Novartis Ag Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity
US6887864B2 (en) 2002-03-12 2005-05-03 Hoffmann-La Roche Inc. Azepane derivatives
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
PL372103A1 (en) 2002-05-16 2005-07-11 Novartis Ag Use of edg receptor binding agents in cancer
WO2004009056A1 (en) * 2002-07-23 2004-01-29 Novartis Ag Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
BRPI0410439A (pt) 2003-05-19 2006-06-06 Irm Llc compostos e composições imunossupressoras
MY150088A (en) 2003-05-19 2013-11-29 Irm Llc Immunosuppressant compounds and compositions
US20040246627A1 (en) * 2003-06-06 2004-12-09 Durrum Thomas M. Disc drive pivot bearing assembly
WO2005014004A1 (en) 2003-08-08 2005-02-17 Novartis Ag Combinations comprising staurosporines
TW200538433A (en) 2004-02-24 2005-12-01 Irm Llc Immunosuppressant compounds and compositiions
GB0512324D0 (en) 2005-06-16 2005-07-27 Novartis Ag Organic compounds
KR20070046906A (ko) * 2004-08-31 2007-05-03 노파르티스 아게 위장관 기질적 종양 치료를 위한 미도스타우린의 용도
JO2897B1 (en) 2004-11-05 2015-09-15 نوفارتيس ايه جي Organic compounds
EP2022498A3 (en) 2005-11-21 2012-08-15 Novartis AG Neuroendocrine tumour treatment
JP2012512885A (ja) 2008-12-18 2012-06-07 ノバルティス アーゲー 新規な塩
CN104803902A (zh) 2008-12-18 2015-07-29 诺华股份有限公司 1-(4-{1-[(e)-4-环己基-3-三氟甲基-苄氧基亚氨基]-乙基}-2-乙基-苄基)-氮杂环丁烷-3-甲酸的半富马酸盐
ES2531831T3 (es) 2008-12-18 2015-03-20 Novartis Ag Forma polimórfica del ácido 1-(4-{1-[(E)-4-ciclohexil-3-trifluorometil-benciloxiimino]-etil}-2-etil-bencil)-azetidin-3-carboxilico
EP2327706A1 (en) * 2009-11-30 2011-06-01 Novartis AG Polymorphous forms III and IV of N-benzoyl-staurosporine
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US8846712B2 (en) 2011-09-12 2014-09-30 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013167403A1 (en) 2012-05-09 2013-11-14 Sanofi Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
WO2019215759A1 (en) * 2018-05-09 2019-11-14 Alaparthi Lakshmi Prasad An improved process for preparation of midostaurin
EP4058465A1 (en) 2019-11-14 2022-09-21 Cohbar Inc. Cxcr4 antagonist peptides
IT202000004291A1 (it) * 2020-03-02 2021-09-02 Indena Spa Processo per la purificazione di alcaloidi indolo carbazolici
CN112812129A (zh) * 2020-12-31 2021-05-18 浙江海正药业股份有限公司 米哚妥林的新晶型及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2766360B2 (ja) * 1988-02-04 1998-06-18 協和醗酵工業株式会社 スタウロスポリン誘導体

Also Published As

Publication number Publication date
NO170634B (no) 1992-08-03
ES2083956T3 (es) 1996-05-01
EP0296110B1 (de) 1996-02-21
HU201329B (en) 1990-10-28
EP0296110A2 (de) 1988-12-21
HK1003788A1 (en) 1998-11-06
KR970001529B1 (ko) 1997-02-11
MY104316A (en) 1994-03-31
NO170634C (no) 1992-11-11
DK324888A (da) 1988-12-16
NO882613L (no) 1988-12-16
DE3855015D1 (de) 1996-03-28
FI882808A0 (fi) 1988-06-13
PT87719A (pt) 1988-07-01
HUT47587A (en) 1989-03-28
IL86632A0 (en) 1988-11-30
IE70523B1 (en) 1996-12-11
CA1337763C (en) 1995-12-19
EP0296110A3 (de) 1991-02-27
FI89362B (fi) 1993-06-15
FI89362C (fi) 1993-09-27
PT87719B (pt) 1992-10-30
JP2708047B2 (ja) 1998-02-04
YU115488A (en) 1989-12-31
DK324888D0 (da) 1988-06-14
DK175507B1 (da) 2004-11-15
NZ225018A (en) 1990-09-26
IE881787L (en) 1988-12-15
AU1757188A (en) 1988-12-15
NO882613D0 (no) 1988-06-14
KR890000494A (ko) 1989-03-15
JPS6434989A (en) 1989-02-06
AU617324B2 (en) 1991-11-28
ATE134375T1 (de) 1996-03-15
GR3019064T3 (en) 1996-05-31

Similar Documents

Publication Publication Date Title
FI882808A (fi) Vid metylaminokvaeve substituerade derivat.
DE59203976D1 (de) Hydantoinderivate.
ES2100907T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion.
MX9301986A (es) Derivados de perhidroisoindol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MA22250A1 (fr) Procede de preparation de derives de piperidine substitues en position 4-
FR2482426B1 (fr) Procede de preparation d'un succedane de blanc d'oeuf a base de proteine de soja
SE8502017D0 (sv) 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same
MA22540A1 (fr) Diaminophtalimides substitues et derives analogues .
MA22251A1 (fr) Procede de preparation de derives de piperidine substitues en position 3
NO173237C (no) Kjemiluminiscerende akridinderivater
DE69735845D1 (de) Kristalle von vitamin d derivaten und verfahren zu ihrer herstellung
ES2038700T3 (es) Procedimiento para la obtencion de alilmercaptoacetil-sidnoniminas.
FR2632521B1 (fr) Nouveaux derives de la phenothiazine, leur preparation et les compositions pharmaceutiques qui les contiennent
ES503895A0 (es) Procedimiento para preparar 3b-hidroximetil-4a-hidroxi-8b- alcoxi-2,9-dioxatriciclo(4,3,1,03,7)decanos
MA22200A1 (fr) Procede de preparation de derives d'aminodiols
BR9202830A (pt) Preparacao de combinacao farmaceutica,processo para sua fabricacao,uso e processo de tratamento ou prevencao de hipertensao
FR2632522B1 (fr) Nouveaux derives de la phenothiazine, leur preparation et les compositions qui les contiennent
FR2659651B1 (fr) Procede de preparation de n-phenyl n'-(cyclo)alkyl paraphenylene diamines.
FR2659650B1 (fr) Procede de preparation de n-phenyl n'-(cyclo)alkyl paraphnylene diamines.
FR2618781B2 (fr) Procede de preparation de derives de la 4,4-dimethyl tetrahydro pyr-2-one
FR2572072B1 (fr) Procede de preparation de derives d'indole
FR2752509B1 (fr) Procede de preparation de succedanes d'oeufs de poisson, tels que des oeufs de saumon ou d'esturgeon
FI963354A0 (fi) Menetelmä piperidiinijohdannaisten valmistamiseksi
ITVA920010A0 (it) Macchina per la preparazione di provini

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

FG Patent granted

Owner name: NOVARTIS AG